Letter: Addressing Gaps in Hospital‐Based Hepatitis C Screening—Insights and Recommendations

医学 梅德林 丙型肝炎 肝炎 重症监护医学 家庭医学 病毒学 政治学 法学
作者
Zhen Deng,Lincheng Duan,Kai Wang
出处
期刊:Alimentary Pharmacology & Therapeutics [Wiley]
卷期号:61 (5): 915-916 被引量:2
标识
DOI:10.1111/apt.18460
摘要

We have carefully reviewed Ferrarese et al.'s study on the effectiveness of hospital-based hepatitis C virus (HCV) screening activities [1]. This research offers crucial data for identifying HCV-infected patients beyond current national screening policies, and provides valuable insights for public health interventions. However, we propose several considerations and recommendations to enhance the study. Firstly, the study does not sufficiently analyse patients' comorbid conditions. Hospitalised patients often have chronic diseases such as diabetes, metabolic syndrome or cardiovascular diseases, which increase HCV infection risk and influence treatment adherence and outcomes [2, 3]. Stratified analysis by comorbidities could clarify the interplay between HCV infection and overall health, aiding in the development of targeted screening and treatment strategies. Secondly, the research inadequately addresses patients' socioeconomic status (SES), a key factor affecting healthcare access and screening participation [4, 5]. Individuals with low-income or education levels may encounter greater barriers due to financial constraints or lack of information [6]. Collecting data on income, education and employment, and examining their impact on screening and treatment, would provide a more comprehensive understanding of how socioeconomic disparities impede HCV prevention and control. Thirdly, while the study notes that 82.5% of hospitalised patients were not screened, it does not examine the specific characteristics of this unscreened group, such as age, gender, comorbidities or departmental distribution. This selection bias may limit the representativeness of the findings. We recommend a retrospective analysis of hospital records to identify traits of the unscreened population, enabling a more accurate assessment of HCV prevalence among hospitalised patients and the creation of more inclusive screening strategies. Additionally, the study finds that female patients with positive viral loads are significantly older than males, while it does not explore the reasons for this gender disparity. This difference might relate to unique risk factors for disease progression in women or barriers to healthcare access. Future research should investigate this phenomenon to optimise screening and treatment approaches for female patients. Lastly, the study mentions that some patients were lost to follow-up after referral to local centres but does not suggest specific improvements for follow-up management. Loss to follow-up can severely impact treatment outcomes, particularly for foreign patients or those with limited medical resources. To address these issues comprehensively, we suggest integrating social work practices to enhance HCV screening and treatment effectiveness. Health education and outreach through community lectures and multilingual support can help high-risk groups understand the importance of screening and overcome cultural or language barriers. Providing financial assistance or mobile screening services for low-income or resource-limited populations can reduce participation barriers. For foreign and female patients, culturally adapted educational materials, flexible screening schedules and childcare services can offer targeted support. Additionally, case management models and digital follow-up tools can improve long-term adherence, while establishing patient support groups and advocating for policy enhancements (such as expanding free screening coverage) can create synergistic effects from grassroots to policy levels. In conclusion, Ferrarese et al. have significantly advanced HCV screening efforts. Addressing the aforementioned issues would enhance the study's credibility and practical applicability, providing more comprehensive scientific support for optimising screening and treatment strategies. Zhen Deng: methodology, formal analysis, writing – original draft. Lincheng Duan: methodology, writing – original draft. Kai Wang: conceptualization, methodology, supervision, writing – review and editing. The authors declare no conflicts of interest. This article is linked to Ferrarese et al papers. To view these articles, visit https://doi.org/10.1111/apt.18433 and https://doi.org/10.1111/apt.18505. The authors have nothing to report.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Mark完成签到 ,获得积分10
1秒前
Zn完成签到 ,获得积分10
3秒前
why发布了新的文献求助10
5秒前
5秒前
TieTie发布了新的文献求助10
5秒前
molihuakai的应助被独享采纳,获得10
6秒前
7秒前
在水一方的应助被辣子鸡采纳,获得10
8秒前
code_Z发布了新的文献求助10
10秒前
学医的小白完成签到,获得积分10
10秒前
天天快乐的应助被半分青蓝采纳,获得10
10秒前
happy发布了新的文献求助10
11秒前
彭于晏的应助被YiLu采纳,获得10
11秒前
大模型的应助被why采纳,获得10
11秒前
13秒前
16秒前
大个的应助被邱静采纳,获得10
17秒前
20秒前
所所的应助被ln采纳,获得10
21秒前
科研通AI6.4的应助被Zn采纳,获得30
22秒前
上官若男的应助被科研通管家采纳,获得10
23秒前
酷波er的应助被科研通管家采纳,获得10
23秒前
斯文败类的应助被科研通管家采纳,获得10
23秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
23秒前
23秒前
6666的应助被科研通管家采纳,获得10
23秒前
23秒前
6666的应助被科研通管家采纳,获得10
23秒前
23秒前
科目三的应助被lizhiqian2024采纳,获得10
24秒前
彭于晏的应助被lizhiqian2024采纳,获得10
24秒前
ding的应助被lizhiqian2024采纳,获得30
24秒前
隐形曼青的应助被坚强惜海采纳,获得10
24秒前
奋斗小吕发布了新的文献求助10
25秒前
汉堡包的应助被applewinwin采纳,获得10
25秒前
一颗葡萄完成签到 ,获得积分10
26秒前
害羞爆米花完成签到,获得积分10
26秒前
27秒前
29秒前
不慌不张完成签到 ,获得积分10
29秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Rosenblum, Global Change Biology 800
The Dawn of Philology 520
Organizational Behavior 510
Management and the Arts 510
Production Logging: Theoretical and Interpretive Elements 400
A primer on partial least squares structural equation modeling (PLS-SEM) (4th ed.) 310
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7819726
求助须知:如何正确求助?哪些是违规求助? 9347410
关于积分的说明 20541107
捐赠科研通 7412159
什么是DOI,文献DOI怎么找? 3332408
关于科研通互助平台的介绍 2478447
邀请新用户注册赠送积分活动 2352136